The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients

NAUnknownINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

June 4, 2019

Study Completion Date

June 4, 2019

Conditions
Burn Surgery
Interventions
DRUG

Vasopressin

Vasopressin, is a hormone synthesized as a peptide prohormone in neurons in the hypothalamus, and is converted to arginine vasopressin. It then travels down the axon of that cell, which terminates in the posterior pituitary, and is released from vesicles into the circulation in response to extracellular fluid hypertonicity (hyperosmolality). Arginine vasopressin has two primary functions. First, it increases the amount of solute-free water reabsorbed back into the circulation from the filtrate in the kidney tubules of the nephrons. Second, arginine vasopressin constricts arterioles, which increases peripheral vascular resistance and raises arterial blood pressure.

Trial Locations (1)

07247

RECRUITING

Hangang Sacred Heart Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

Hangang Sacred Heart Hospital

OTHER

NCT03590873 - The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients | Biotech Hunter | Biotech Hunter